Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jan 01, 2010 (Vol. 30, No. 1)

GenePattern

URL:www.broadinstitute.org/cancer/software/genepattern
  • A large collection of data-analysis modules
  • None

It is very fitting that GenePattern is the brainchild of Harvard and MIT’s Broad Institute, as it certainly is very broad in scope. It provides over 100 modules to help analyze genetic data, particularly those obtained from large-scale gene-expression analyses like microarrays. The modules are grouped into categories such as annotation, clustering, flow cytometry, image creators (make your very own microarray heat map), SNP analysis, and proteomics. (If that didn’t whet your appetite for this site, then I don’t know what will!) GenePattern is free to download, but it can also be used online. All that is required is (free) registration. There is plenty of user support, including video tutorials and a step-by-step user’s guide. Additionally, the website has a user-friendly interface. Before you know it, you’ll be well on your way to the next major breakthrough in genomics!

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »